Palo Alto Investors as of June 30, 2021
Portfolio Holdings for Palo Alto Investors
Palo Alto Investors holds 42 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Staar Surgical Com Par $.01 (STAA) | 10.7 | $193M | 1.3M | 152.50 | |
| BioMarin Pharmaceutical (BMRN) | 10.2 | $185M | 2.2M | 83.44 | |
| Abiomed | 10.0 | $182M | 584k | 312.11 | |
| Insmed Com Par $.01 (INSM) | 9.4 | $171M | 6.0M | 28.46 | |
| Biogen Idec (BIIB) | 6.9 | $125M | 362k | 346.27 | |
| United Therapeutics Corporation (UTHR) | 6.8 | $123M | 687k | 179.41 | |
| Amicus Therapeutics (FOLD) | 5.3 | $96M | 10M | 9.64 | |
| Revance Therapeutics (RVNC) | 5.2 | $95M | 3.2M | 29.64 | |
| Prothena Corp SHS (PRTA) | 4.9 | $89M | 1.7M | 51.41 | |
| Vanda Pharmaceuticals (VNDA) | 4.5 | $82M | 3.8M | 21.51 | |
| eHealth (EHTH) | 3.7 | $67M | 1.1M | 58.40 | |
| ACADIA Pharmaceuticals (ACAD) | 3.1 | $57M | 2.3M | 24.39 | |
| Epizyme | 3.1 | $57M | 6.9M | 8.31 | |
| Karyopharm Therapeutics (KPTI) | 3.1 | $56M | 5.4M | 10.32 | |
| Sage Therapeutics (SAGE) | 1.9 | $34M | 601k | 56.81 | |
| Align Technology (ALGN) | 1.9 | $34M | 55k | 610.99 | |
| Clovis Oncology | 1.4 | $26M | 4.5M | 5.80 | |
| Gritstone Oncology Ord (GRTS) | 1.2 | $22M | 2.4M | 9.13 | |
| Alexion Pharmaceuticals | 1.0 | $17M | 95k | 183.71 | |
| Gossamer Bio (GOSS) | 0.8 | $14M | 1.8M | 8.12 | |
| Puma Biotechnology (PBYI) | 0.7 | $13M | 1.4M | 9.18 | |
| Dicerna Pharmaceuticals | 0.7 | $12M | 333k | 37.32 | |
| Alkermes SHS (ALKS) | 0.7 | $12M | 487k | 24.52 | |
| Anaptysbio Inc Common (ANAB) | 0.6 | $11M | 437k | 25.93 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $6.9M | 401k | 17.17 | |
| Kaleido Biosciences Ord (KLDO) | 0.3 | $5.9M | 786k | 7.44 | |
| Magenta Therapeutics | 0.2 | $4.2M | 432k | 9.78 | |
| Zogenix Com New | 0.2 | $3.7M | 215k | 17.28 | |
| Kezar Life Sciences (KZR) | 0.2 | $3.6M | 656k | 5.43 | |
| Rigel Pharmaceuticals Com New | 0.2 | $2.8M | 652k | 4.34 | |
| Cytokinetics Com New (CYTK) | 0.1 | $2.4M | 124k | 19.79 | |
| Travere Therapeutics (TVTX) | 0.1 | $2.4M | 166k | 14.59 | |
| Alimera Sciences Com New | 0.1 | $1.8M | 201k | 9.10 | |
| Aldeyra Therapeutics (ALDX) | 0.1 | $1.8M | 161k | 11.33 | |
| Athenex | 0.1 | $1.5M | 318k | 4.62 | |
| Tactile Systems Technology, In (TCMD) | 0.1 | $1.4M | 27k | 51.99 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.0 | $562k | 31k | 17.94 | |
| Syros Pharmaceuticals | 0.0 | $439k | 81k | 5.45 | |
| Viracta Therapeutics (VIRX) | 0.0 | $377k | 33k | 11.35 | |
| Urogen Pharma (URGN) | 0.0 | $374k | 25k | 15.27 | |
| Idera Pharmaceuticals Com Par | 0.0 | $92k | 77k | 1.19 | |
| Minerva Neurosciences | 0.0 | $84k | 36k | 2.31 |
